Abstract
Introduction: In myocardial perfusion imaging, reducing the number of photons in images of obese patients causes poor image quality. To solve this problem, we need to inject the tracer according to the patients' weight. Therefore, this study aimed to investigate the relationship between myocardial photon counts with patients' weight, BMI, and gender.
Materials and Methods: A total of 129 patients underwent myocardial perfusion imaging in a twoday
stress-first protocol, but only rest images were included in this study. Multiplication factor
was used to determine the amount of
radiopharmaceutical activity injected into the patients. For evaluating the effect of gender, the photon
counts of 22 female patients were also assessed when the breast tissue was pulled upward
(Breast Up). The total myocardial detector counts in the raw images were calculated from the summation
of 32 projections. A multiple linear regression test was used to simultaneously examine the
effects of weight, BMI, and gender on photon counts.
Results: There was no significant relationship between photon counts and patients' weight (p=0.129) and BMI (0.406), but gender had significant effects on photon counts, and myocardial detector counts were found to be higher in males (p=0.00). There was a statistically significant difference between the images of Breast Up and Non-Breast Up, and myocardial detector counts were higher in the Breast Up imaging method (p=0.00).
Conclusion: Using the bodyweight formula, the image quality was comparable in obese and lean patients, but myocardial detector counts were lower in females, and this formula needs to be adjusted according to the patient's gender.
Keywords: Myocardial perfusion imaging, SPECT, radiopharmaceutical activity, 99mTc-Sestamibi, coronary artery disease, body weight.
Graphical Abstract
Current Radiopharmaceuticals
Title:Assessment Relation of Myocardial Detector Counts and Administered Activity of 99mTc-SestaMIBI in MPI: The Effects of Body Weight, BMI, and Gender
Volume: 15 Issue: 2
Author(s): Mahdi Mazinani, Mohammad Ali Tajik-Mansoury*, Mahsa Sabour, Majid Jadidi, Milad Peer- Firozjaei and Nader Asadian
Affiliation:
- Department of Medical Physics, Semnan University of Medical Sciences, Semnan, Iran
- Raaheaseman Center of Nuclear Medicine, Semnan University of Medical Science, Semnan, Iran
Keywords: Myocardial perfusion imaging, SPECT, radiopharmaceutical activity, 99mTc-Sestamibi, coronary artery disease, body weight.
Abstract:
Introduction: In myocardial perfusion imaging, reducing the number of photons in images of obese patients causes poor image quality. To solve this problem, we need to inject the tracer according to the patients' weight. Therefore, this study aimed to investigate the relationship between myocardial photon counts with patients' weight, BMI, and gender.
Materials and Methods: A total of 129 patients underwent myocardial perfusion imaging in a twoday
stress-first protocol, but only rest images were included in this study. Multiplication factor
was used to determine the amount of
radiopharmaceutical activity injected into the patients. For evaluating the effect of gender, the photon
counts of 22 female patients were also assessed when the breast tissue was pulled upward
(Breast Up). The total myocardial detector counts in the raw images were calculated from the summation
of 32 projections. A multiple linear regression test was used to simultaneously examine the
effects of weight, BMI, and gender on photon counts.
Results: There was no significant relationship between photon counts and patients' weight (p=0.129) and BMI (0.406), but gender had significant effects on photon counts, and myocardial detector counts were found to be higher in males (p=0.00). There was a statistically significant difference between the images of Breast Up and Non-Breast Up, and myocardial detector counts were higher in the Breast Up imaging method (p=0.00).
Conclusion: Using the bodyweight formula, the image quality was comparable in obese and lean patients, but myocardial detector counts were lower in females, and this formula needs to be adjusted according to the patient's gender.
Export Options
About this article
Cite this article as:
Mazinani Mahdi, Tajik-Mansoury Ali Mohammad*, Sabour Mahsa , Jadidi Majid , Peer- Firozjaei Milad and Asadian Nader , Assessment Relation of Myocardial Detector Counts and Administered Activity of 99mTc-SestaMIBI in MPI: The Effects of Body Weight, BMI, and Gender, Current Radiopharmaceuticals 2022; 15 (2) . https://dx.doi.org/10.2174/1874471014666210426112933
DOI https://dx.doi.org/10.2174/1874471014666210426112933 |
Print ISSN 1874-4710 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4729 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Studies of QSAR on Inhibitors of Estrogen Receptor and Human Eosinophil Phosphodiesterase
Current Computer-Aided Drug Design Post-Exercise Ketosis, Salivary Uric Acid and Interleukin-6 after a Simulated Wheelchair Basketball Match
Endocrine, Metabolic & Immune Disorders - Drug Targets Omega-3 Fatty Acids for Nutrition and Medicine: Considering Microalgae Oil as a Vegetarian Source of EPA and DHA
Current Diabetes Reviews MicroRNA-208a Potentiates Angiotensin II-triggered Cardiac Myoblasts Apoptosis via Inhibiting Nemo-like Kinase (NLK)
Current Pharmaceutical Design Design, Synthesis and In Vitro Evaluation of 4-Androstene-3,17-dione/Adenosine Hybrid Compounds as Bisubstrate Inhibitors of Type 3 17β-Hydroxysteroid Dehydrogenase
Medicinal Chemistry Targeting Apoptosis Pathway with Natural Terpenoids: Implications for Treatment of Breast and Prostate Cancer
Current Drug Targets Inhibition of Hyaluronan Synthase-3 Decreases Subcutaneous Colon Cancer Growth by Increasing Apoptosis
Anti-Cancer Agents in Medicinal Chemistry Manipulating the Ability of Substituted Titanocene Derivatives to Induce Apoptosis in Castrate-Resistant Prostate Cancer Cells
Letters in Drug Design & Discovery Mesenchymal Stem Cells: New Approaches for the Treatment of Neurological Diseases
Current Stem Cell Research & Therapy Epstein-Barr Virus-associated Gastric Cancer and Potential Mechanisms of Oncogenesis
Current Cancer Drug Targets Are the Myokines the Mediators of Physical Activity-Induced Health Benefits?
Current Pharmaceutical Design Extracellular Vesicles as Innovative Tools for Assessing Adverse Effects of Immunosuppressant Drugs
Current Medicinal Chemistry Recent Developments on 1,2,4-Triazole Nucleus in Anticancer Compounds: A Review
Anti-Cancer Agents in Medicinal Chemistry LncRNA HOTAIR Polymorphisms Association with Cancer Susceptibility in Different Tumor Types
Current Drug Targets Biomedical Applications of Superparamagnetic Nanoparticles in Molecular Scale
Current Organic Chemistry Multifunctional Targeted Radiotherapy System for Induced Tumours Expressing Gastrin-releasing Peptide Receptors
Current Nanoscience DNA Methylation: A Possible Target for Current and Future Studies on Cancer?
Epigenetic Diagnosis & Therapy (Discontinued) Receptor Tyrosine Kinases as Therapeutic Targets in Malignant Glioma
Reviews on Recent Clinical Trials Drug Discovery and Protein Tyrosine Phosphatases
Current Medicinal Chemistry Molecular Biology of Nucleoside Transporters and their Distributions and Functions in the Brain
Current Topics in Medicinal Chemistry